Krungthai XSpring

Krungthai XSpring is a full service broker. The company provides a wide range of investment services such as Securities Brokerage, Derivative Agent Business, Securities Borrowing and Lending, Securities Trading, Underwriting, Financial Advisory, Wealth Advisory, Private Fund Management and International Markets Securities Trading. 

In terms of credibility, Fitch Ratings has assigned Krunghtai XSpring a long-term rating of AA- and a national short-term rating of F1+ with stable outlook.

A full service Thai brokerage

Head of Research, Krungthai XSpring

Waraporn Wiboonkanarak

Head of Research

Equity Bottom-Up

<ul><li>MEDEZE is a pioneering company in stem cell and immune cell innovation, adhering to global standards.</li><li>The company is entering a growth phase, driven by increasing demand, the introduction of new services, and enhanced operational efficiency through innovation.</li><li>We estimate a fair value for MEDEZE of Bt11.05, using the earnings yield method, based on the projected earnings per share (EPS) for 2025E, discounted by a required return of 3.7%. This price level corresponds to a 2025E PER of 27.3x.</li></ul>

MEDEZE is a pioneering company in stem cell and immune cell innovation, adhering to global standards.The company is entering a growth phase, driven by increasing demand, the introduction of new services, and enhanced operational efficiency through innovation.We estimate a fair value for MEDEZE of Bt11.05, using the earnings yield method, based on the projected earnings per share (EPS) for 2025E, discounted by a required return of 3.7%. This price level corresponds to a 2025E PER of 27.3x.

Medeze Group - MEDEZE and Its Biotechnology for Sustainable Health